-
Puma Biotechnology: Investment (NASDAQ:PBYI) Seeking Alpha
ID: b1sYhS9FAO
From:
-
Biotechnology
ID: ewzGrFGA9i
From:
-
Puma Stock News (PBYI) 2 - Public.com
ID: 9s8UL7vtAw
From:
-
Biotechnology Publishes P-II Trial (TBCRC041) Results of Alisertib for Endocrine-Resistant Advanced Breast in
ID: cUxO636JRE
From:
-
Puma Biotechnology: Investment (NASDAQ:PBYI) Seeking Alpha
ID: KoDlOZfrHW
From:
-
Puma to Present at the Cantor Virtual Global Conference | Business Wire
ID: 0Ro1q5jscZ
From:
-
Puma Biotech Wider Than Expected, Sales Top | Nasdaq
ID: OkMSP5KCkY
From:
-
Puma Announces Litigation with Decision
ID: 7CPyk8g0Gy
From:
-
Puma Biotechnology, Inc. Stock Price, News - Stock Analysis
ID: 1LWj9CwqHc
From:
-
Puma Biotechnology and Pierre Fabre Enter into Exclusive License Agreement Develop and NERLYNX® in
ID: Hf850olB3s
From:
-
Biotechnology to Participate in Citi's Biotech Conference
ID: JacFOACUNC
From:
-
Puma Biotechnology: Investment (NASDAQ:PBYI) Seeking Alpha
ID: p04ON6ndgD
From:
-
Puma Biotechnology Secures $125 Million Note by Capital | Business Wire
ID: MspR7ajW7s
From:
-
Puma Announces Exclusive License Agreement with Takeda for the Development and Commercialization of an Investigational Kinase A | Business Wire
ID: 8K9NOqYZHX
From:
-
Biotechnology
ID: FNEIwDgyc4
From:
-
Puma Biotechnology Releases Corporate Presentation
ID: htXiBFMoiR
From:
-
Puma Biotechnology, Inc. Stock Price, News - Stock Analysis
ID: BbiWnxPJbn
From:
-
Puma Biotechnology Evaluate
ID: 4rwZGS8IUj
From:
-
Puma Stock News (PBYI) 2 - Public.com
ID: uWhjTdrAlq
From:
-
Puma Biotechnology Inc (PBYI) Stock Today, Quotes, and
ID: IfqoOauZ2e
From:
-
Puma Biotechnology, Inc. Stock Price, News - Stock Analysis
ID: bv01b54lc1
From:
-
Pint-Pharma - Puma Biotechnology and Pint Pharma into Exclusive Licensing Agreement to Commercialize (neratinib) in Latin
ID: A0KRijYT1c
From:
-
Puma Biotech agrees to pay $54.2 mln in fraud case | Reuters
ID: kjdLDeuQZA
From:
-
Biotechnology - Crunchbase Company Profile & Funding
ID: LK8HuWgpg0
From:
-
Does Puma's quick Nerlynx play into its prospects? | Pharma
ID: UWcongSu7X
From: